Bio-Techne (TECH) Depreciation & Amortization (CF) (2016 - 2026)
Bio-Techne has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $24.7 million for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) fell 8.77% year-over-year to $24.7 million; the TTM value through Dec 2025 reached $103.7 million, down 6.2%, while the annual FY2025 figure was $109.9 million, 1.62% down from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $24.7 million at Bio-Techne, up from $24.3 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $28.5 million in Q3 2023 and troughed at $21.1 million in Q1 2021.
- A 5-year average of $26.2 million and a median of $26.8 million in 2022 define the central range for Depreciation & Amortization (CF).
- Biggest five-year swings in Depreciation & Amortization (CF): grew 20.21% in 2022 and later fell 13.49% in 2025.
- Year by year, Depreciation & Amortization (CF) stood at $25.1 million in 2021, then increased by 6.38% to $26.7 million in 2022, then grew by 4.12% to $27.8 million in 2023, then dropped by 2.59% to $27.1 million in 2024, then dropped by 8.77% to $24.7 million in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for TECH at $24.7 million in Q4 2025, $24.3 million in Q3 2025, and $27.1 million in Q2 2025.